USE OF N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-?á1,3,4-OXADIAZOL-2-YL?åPHENYL)PYRIDINE-3-SULPHONAMIDE IN THE TREATMENT OF CANCER

The use of N -(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide, or a pharmaceutically acceptable salt thereof, in the treatment of cancer and/or pain in a warm blooded animal such as man is described.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HUGHES ANDREW MARK, TAYLOR SIAN TOMIKO, BARRASS NIGEL CHARLES, BOYLE FRANCIS THOMAS, ASHFORD MARIANNE BERNICE, TONGE DAVID WILLIAM, JOHNSTONE DONNA
Format:	Patent
Sprache:	eng ; slv
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The use of N -(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide, or a pharmaceutically acceptable salt thereof, in the treatment of cancer and/or pain in a warm blooded animal such as man is described.